Overview Safety of Xeloda in Solid Tumours Status: Completed Trial end date: 2009-06-01 Target enrollment: Participant gender: Summary The primary objective of this study is to observe safety and tolerability of Xeloda as used in medical practice, alone and in combination with docetaxel. Details Lead Sponsor: Hoffmann-La RocheTreatments: CapecitabineDocetaxel